Adverse events96

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 96

Type	Event	Organ system	Group	Affected	At risk	Events
other	Grade 3 or 4 anemia	Blood and lymphatic system disorders	High Dose RIF With LZD	0	9	0
other	Grade 3 or 4 anemia	Blood and lymphatic system disorders	Standard Dose RIF With LZD	1	11	1
other	Grade 3 or 4 anemia	Blood and lymphatic system disorders	High Dose RIF	1	10	1
other	Grade 3 or 4 anemia	Blood and lymphatic system disorders	Standard Dose RIF	2	10	2
other	Grade 3 or 4 hyponatremia	Blood and lymphatic system disorders	High Dose RIF With LZD	0	9	0
other	Grade 3 or 4 hyponatremia	Blood and lymphatic system disorders	Standard Dose RIF With LZD	3	11	3
other	Grade 3 or 4 hyponatremia	Blood and lymphatic system disorders	High Dose RIF	4	10	4
other	Grade 3 or 4 hyponatremia	Blood and lymphatic system disorders	Standard Dose RIF	3	10	3
other	Grade 3 or 4 elevated total bilirubin	Hepatobiliary disorders	High Dose RIF With LZD	0	9	0
other	Grade 3 or 4 elevated total bilirubin	Hepatobiliary disorders	Standard Dose RIF With LZD	0	11	0
other	Grade 3 or 4 elevated total bilirubin	Hepatobiliary disorders	High Dose RIF	1	10	1
other	Grade 3 or 4 elevated total bilirubin	Hepatobiliary disorders	Standard Dose RIF	0	10	0
serious	Sepsis Secondary to Multiple Pressure Sores	Skin and subcutaneous tissue disorders	High Dose RIF With LZD	0	9	0
serious	Sepsis Secondary to Multiple Pressure Sores	Skin and subcutaneous tissue disorders	Standard Dose RIF With LZD	0	11	0
serious	Sepsis Secondary to Multiple Pressure Sores	Skin and subcutaneous tissue disorders	High Dose RIF	1	10	1
serious	Sepsis Secondary to Multiple Pressure Sores	Skin and subcutaneous tissue disorders	Standard Dose RIF	0	10	0
serious	Drug-Induced Liver Injury	Hepatobiliary disorders	High Dose RIF With LZD	0	9	0
serious	Drug-Induced Liver Injury	Hepatobiliary disorders	Standard Dose RIF With LZD	0	11	0
serious	Drug-Induced Liver Injury	Hepatobiliary disorders	High Dose RIF	1	10	1
serious	Drug-Induced Liver Injury	Hepatobiliary disorders	Standard Dose RIF	0	10	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04021121/events

API reference For AI assistants

Adverse events96

Sources 3

Read this list from software.